This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
A First look at the new approval for Dupixent in treating prurigo nodularis
Ticker(s): SNY, REGNWho's the expert?
Institution: CSC Dermatology
- Paula S. Malhotra, MD, is a board-certified dermatologist specializing in comprehensive medical and cosmetic skin care.
- Currently manages 10-20 prurigo nodularis patients
- Specializes in injectables such as Botox, Dysport, Juvederm, Restylane, Sculptra, Kybella, PRP, and laser procedures for red blood vessels, brown spots, and laser resurfacing.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
